Summary.-Cells of the methylene dimethanesulphonate -(MDMS) -resistant Yoshida sarcoma cell line contain a low molecular weight " resistance factor " which is present in the culture medium of these cells and may be utilized by MDMS-sensitive Yoshida sarcoma cells either by co-culturing the two cell lines or by culturing the MDMS-sensitive Yoshida cells in a medium containing 20% used medium of MDMSresistant Yoshida cells or in the presence of dialysed medium from resistant cells. The " resistance factor " does not inactivate the drug itself or its metabolites, and it has no influence on the sensitivity of the cells if added after MDMS treatment. Twenty-four hours seems to be enough time for the transfer of the resistance factor, but its effect on whole populations decreases within 24 hours of ceasing the supply. The relationship between these findings and the known phenomena of metabolic co-operation are discussed.
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METABOLIC co-operatioin has been
demonstrated by a number of workers (Subak-Sharpe, Btirk and Pitts, 1969; Van Diggelen, Van Zeeland and Simons, 1972; Fujimoto and Seigmiller, 1970; Ashkenazi and Gartler, 1971 ) between cultured cells showing a deficiency in the enzyme HG-PRT (hypoxanthineguanine phosphoribosyl transferase) which confers resistance to the antimetabolite 8-azaguanine and wild-type cells which are sensitive to the drug. Most of the data are consistent with the idea that co-operation occurs by cell-cell contact, but some workers (Fujimoto and Seigmiller, 1970 and Ashkenazi and Gartler, 1971 ) have provided additional evidence that transfer may occur via mRNA or proteins, since HG-PRT negative cells can reacquire the enzyme and become sensitive to azaguanine after the addition of a 10,000 g supernate from wild-type cells or by the addition of conditioned media from dense wild-type cultures (Ashkenazi and Gartler, 1971) .
The above phenomenon is well documented in the case of HG-PRT, has been observed for other phenotypes, and concerns the acquisition of drug sensitivity by resistant cells. On the other hand, there is relatively little information about transfer of resistance, in particular that to alkylating agents to sensitive cells.
The only case appears to be that reported by Ujhazy (1969) 
MATERIALS ANI) METHODS
The MDMS-sensitive (YS) and MDMSresistant (YR) Yoshida sarcoma cell lines were used, developed in vivo by Fox (1969) and isolated in vitro by Fox and Fox (1971) . MDMS was prepared as described previously (Fox and Jackson, 1965) .
The cells were cultured in suspension using Fischer's medium containing 2(0% horse serum (HOS). Treatment was carried out during the exponential phase (1-2 x 105 cells/ml) of proliferation of the cells using drug dissolved in appropriate concentrations in physiological saline and sterilized by Millipore filtration. Plating in soft agar and determination of survival by extrapolation of growth curves were carried out according to the methods used in this laboratory as described previously (Fox and Fox, 1971) . Autoradiography was carried out as described by Fox and Gilbert (1966) .
The following experimental models were used:
Co-culture of cells.-We have previously demonstrated that YR cells are unable to form colonies in soft agar (Fox and Fox, 1971) . Therefore co-culture experiments were undertaken with the expectation that any colonies produced had a high probability of being derived from sensitive cells. 3. Dialysis of medium of exponentially growing YR cells in the presence of YS cells.-Since, in using the 2 methods just described, it was possible that some contamination of sensitive cells by resistant cells could occur, 2 ml of normal medium containing exponentially growing YR cells (approximately 4 x 105 cells/ml) wiere inoculated into a plastic dialysis bag previously sterilized by exposure to u.v. light (18 hours at dose rate -10 erg/see) and the bag suspended in a bottle which contained exponentially growing YS (20 ml 5 x 104 cells/ml) cells in normal growth medium. After 24 hours the bag wa.s removed, together with the YR cells, and the YS cells were harvested and subsequently treated with MDMS and plated in soft agar using normal medium.
RESULTS

C"o-culture of sensitive and resistant cells
The results of the experiments using co-cultured cells are summarized in Fig. 1 Fox and Gilbert (1966) . Slides were exposed for 7 days and then the percentage of labelled cells was determined by scoring 5000 cells.
The cell population contained 60% YS cells and 4000 YR cells the proportion which would be expected, taking into account the very similar growth rate of the 2 cell lines reported before (Fox and Fox, 1971) and also found in our recent experiments. No phagocytosis of labelled cell particles by unlabelled cells was observed.
Characterization of colonies surviving MDMS treatment after co-cultutre If the colonies surviving MDMS treatment after co-culture of sensitive and resistant cells are truly derived from sensitive cells then they should (a) retain their agar colony forming ability and (b) retain some evidence of transferred resistance. The following experiment was therefore performed:
A 1000 sensitive: 90°, resistant cell mixture was prepared and co-cultured in suspension for 24 hours. Aliquots of the mixture were then plated in agar with or without exposure to 40 /tg/ml MDMS.
After incubation for 10 days, colonies were isolated from control untreated mixed cultures S/RC and treated mixed cultures S/R40 and grown in suspension until enough cells were available for further testing. method (Fox and Fox, 1971) Effect of conditioned medium on the rate of breakdown of MDMS To determine whether there was a factor present in the YRM which was capable of accelerating the rate of drug breakdown, sensitive cells were treated with MDMS for 30 minutes in the presence of 20% YRM. Cells were then washed free of drug and conditioned medium and plated in soft agar. In addition, the effect of adding the YRM after treatment of sensitive cells with MDMS was determined to test whether protection could be afforded by post-treatment. Fig. 4 shows the dose response curves of the 2 experiments. There is a slight decrease of sensitivity in the low dose range when treatment was carried out in 20% YRM; otherwise the curves closely resemble the control curve. This slight decrease appears to reflect the multicomponent nature of the dose response curves as seen during development of resistance ( Fig. 1 and 3 suggests that the "resistance factor" passes through the pores of the dialysis bag; therefore its molecular weight is lower than 10,000. The protective effect of the dialysed medium was approximately equal to the effect observed when 40°, or 10% conditioned medium was used for culture of cells 24 hours before treatment. As a control to the above, in a separate experiment YS cells were cultured for 24 hours in the medium from inside the dialysis bag, from which the YR cells had been removed by centrifugation after they had been cultured inside the dialysis bag in the presence of sensitive cells for 24 hours. No protective effect of this " spent " medium was observed. This result suggests that the " resistance factor" diffuses through the dialysis membrane as rapidly as it is produced, and that it is equally rapidly absorbed by sensitive cells if they are present. (Szende and Fox, 1973) The reduced effectiveness of high concentrations of conditioned medium may be due (a) to the presence of some toxic metabolites from resistant cells, as evidenced by a reduction in plating efficiency in cultures exposed to conditioned medium but no drug or (b) to the exhaustion of some growth promoting factors during the production of the conditioned medium.
In conclusion, therefore, we suggest that after the first treatment with a drug, a small proportion of the whole population survives which is resistant to this drug either by selection or as a result of mutation. Such cells release the proposed " resistance factor " into the intercellular fluid and it is then transferred to other drug sensitive cells. Thus, at the time of the second treatment a much higher number of cells survive and they, in addition to the resistance developed by absorption of the factor, may develop their own resistance due to further selection. In this way, resistance of the majority of the cell population could develop after a single treatment, as is observed in some instances after in vivo exposure of the Yoshida sarcoma to MDMS (Fox, 1969) .
Extrapolation of this finding to the field of cancer chemotherapy suggests that the frequenev of administration of certain drugs may be too high, and that less frequent drug administration, or more frequent alteration of the nature of the chemotherapeutic agent, could lead to a slowing down of the development of resistance of tumours to chemotherapeutic agents.
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